Eileen E. Ming, MPH, ScD, FISPE, Epi Excellence LLC

Eileen E. Ming, MPH, ScD, FISPE, founded Epi Excellence, an epidemiology consulting firm, in 2014 following an extensive record of success as an epidemiologist, pharmacoepidemiologist, outcomes researcher, and leader in the pharmaceutical industry. She served as an outcomes researcher at Merck, an epidemiologist at AstraZeneca, and the head of global epidemiology and pharmacoepidemiology at Shire Pharmaceuticals. She has worked across a variety of therapeutic areas, from pre-clinical through post-marketing phases, providing epidemiologic strategic and tactical expertise to commercial, clinical development, market access, medical affairs, regulatory, and pharmacovigilance activities.

Eileen is an Adjunct Scholar of the Center for Clinical Epidemiology and Biostatistics, and an Adjunct Investigator of the Center for Pharmacoepidemiology Research and Training, at the Perelman School of Medicine at the University of Pennsylvania. She is a Fellow of the International Society for Pharmacoepidemiology. She received her epidemiology training at the Harvard T.H. Chan School of Public Health (ScD in Epidemiology, concentration in Psychiatric Epidemiology, minors in Biostatistics, and Health and Social Behavior) and the Johns Hopkins Bloomberg School of Public Health (MPH), where she was inducted into the Delta Omega Public Health Honor Society. She earned her undergraduate degree in Human Biology from Stanford University.

MPH, ScD, FISPE